Introduction
Relapse of acute lymphoblastic leukaemia (ALL) causes significant morbidity, with up to 60% of adult cases failing to be cured. 1 Extramedullary relapse is seldom isolated to one site, and almost always coexists with, or heralds extensive marrow disease. 2 Leukaemic infiltration of the myocardium is a well described entity, being confirmed in up to 44% of patients at post-mortem examination; however, ante-mortem clinical diagnosis remains difficult and rare. 3, 4 As a result, myocardial involvement in the absence of any other foci of relapse has only seldom been reported. 5, 6 Here, we present an unusual and rare case of isolated gross intracardiac relapse of ALL in a patient presenting with chest pain and fevers.
Learning points
• Whilst leukaemic infiltration of myocardial cells is relatively common, diagnosis is often only made post-mortem.
• Cardiac magnetic resonance imaging may be a useful tool in the assessment and diagnosis of myocardial leukaemic infiltrate.
• Isolated myocardial relapse of leukaemia is seldom seen but typically heralds fulminant relapse.
• The myocardium may present as a sanctuary site for leukaemic cells. 
Timeline Case report
A 39-year-old female patient presented to our facility with a 2-day history of fevers, malaise, and central dull chest pain that was neither pleuritic nor altered by position. She had a past history of relapsing Philadelphia-positive ALL for which she had received two consecutive allogeneic stem cell transplants (SCT) from a sibling donor, as well as an infusion of donor lymphocytes. She had no previous history of cardiovascular disease and at the time of presentation had been in remission from her ALL for 6 months. Her post-remission course had been uneventful prior to her emergency presentation. Figure 1) . A transthoracic echocardiogram demonstrated mild-moderate left ventricular hypertrophy with anterior and anteroapical hypokinesis and a small circumferential pericardial effusion. The left ventricular size was normal, but systolic function was impaired with a left ventricular ejection fraction of 45%. There was no significant valvular pathology ( Figure 2 ). Coronary angiography did not reveal significant obstructive disease.
The patient was resuscitated with IV fluids, given tazocin 4.5 g 6 hourly and commenced on therapy for presumed severe myopericarditis, receiving pulsed 1 g intravenous methylprednisolone daily for 3 days; however, failed to respond with ongoing fevers, tachycardia, and hypotension. Differential diagnoses including infiltrative, tachycardic, and catecholaminergic cardiomyopathies were considered. In the absence of a clear aetiology and given her failure to respond to initial therapy, an urgent cardiac magnetic resonance imaging (CMR) was sought. Cardiac magnetic resonance imaging identified severe, patchy increased signal intensity involving the myocardium and pericardium in the basal antero-septum, anterior wall, mid-lateral wall, and the distal interventricular septum on oedema-weighted, and late gadolinium sequences with associated regional wall motion abnormalities consistent with severe myocarditis ( Figure 3) .
She subsequently underwent transjugular endomyocardial biopsy (EMBx). Endomyocardial biopsy revealed a heavy infiltrate of malignant lymphocytes percolating between myocytes (Figure 4) , with resultant atrophy of the intervening myocardial fibres as well as an accumulation of the malignant cells in a prominent perivascular and pericardial distribution (Figure 4) , confirming a leukaemic infiltrate in Figure 6A ) and DXZ1 (X centromere), DYZ1(Yq12) loci-specific probe set confirmed that the majority of the cells contained recipient (XX) origin, with only occasional donor (XY) cells noted ( Figure 6B ). These findings were in keeping with recurrence of the patient's ALL.
Her clinical course was complicated by runs of non-sustained ventricular tachycardia (treated with amiodarone 300 mg orally thrice daily in a weaning regimen and coupled with low-dose bisoprolol 2.5 mg daily, titrated to blood pressure), persistent fevers, and intermittent chest pain with associated changes in serum troponin. Within 2 weeks of confirmation of diagnosis by EMBx the patient had evidence of lymphoblasts (50%) in her peripheral blood. She was commenced on a second-line compassionate-access tyrosine kinase inhibitor, Ponatinib (45 mg orally once daily), as a palliative measure, though she failed to respond and by 4 weeks her blast count was 23.71 Â 10 9 /L with a doubling time of under 24 h. She soon thereafter died from fulminant multi-organ failure.
Discussion
Involvement of the myocardium by leukaemic cells is an entity that has been well established since the 1940s and is usually an incidental finding at autopsy. 4 In one of the largest post-mortem studies of hearts from children with leukaemia, Sumners et al. reported that 44% of hearts had at least one myocardial area of leukaemic involvement. Factors that have been postulated to influence the occurrence of cardiac involvement include duration of disease, degree of lymphocytosis, and subtype of malignancy, though there are likely many other mediators yet to be identified. The occurrence of isolated myocardial ALL relapse is very rare, and to the best of our knowledge, isolated myocardial relapse following SCT has only been reported in one patient. 7 Despite evidence to support a positive correlation between peripheral lymphocyte count and myocardial infiltration, 4 our case highlights the interesting occurrence of myocardial infiltration with a complete absence of a peripheral lymphoblastosis. This has been reported in only two other patients. 6, 7 We propose one possible mechanism is our patient's history of multiple relapses, which may have led to significant net cardiac exposure by leukaemic cells over time, leading to greater likelihood of infiltration. Similarly, it has been hypothesized that atypical extramedullary sites may represent sanctuary sites for the conditioning chemoradiotherapy. 8 Further to this, it is possible that the graft-vs.-leukaemia (GVL) phenomenon may be less potent in peripheral tissues compared to bone marrow. This may leave the myocardium with unchecked exposure to seeded malignant cells, due to either an absence of GVL effector cells or an inherently unsuitable molecular environment for these cells to function. 9 Although EMBx is generally an accepted requirement for the diagnosis of myocardial involvement by leukaemic cells, multiple imaging modalities, particularly CMR, may play an increasing role in the diagnostic work up. 6, 10 Hori et al. 7 hinged their diagnosis of myocardial relapse on combined CT, MRI, and gallium scintigraphy findings in the absence of a tissue specimen, and this guided at least temporarily successful treatment. Similarly, Baritussio et al. 11 presented a case of disseminated ALL in which the CMR features showed infiltration in a pattern and distribution similar to our case. Nevertheless, there remains a paucity of data with respect to reliable imaging findings that may assist in the prediction of cardiac involvement, and our case is the only one in the literature to utilize CMR in the diagnosis of isolated myocardial relapse of ALL. With ongoing improvements in the management of leukaemia, the incidence of myocardial involvement causing clinical disease may increase due to the mechanisms aforementioned. As such, consideration around the surveillance for recurrence in known sanctuary sites may be warranted in the correct clinical context. Our paper may encourage clinicians to consider using advanced imaging techniques in the early assessment of patients at-risk of cardiac involvement. Further case reports and observational data, particularly utilizing CMR will help to identify imaging indicators of leukaemic involvement of the myocardium.
Supplementary material
Supplementary material is available at European Heart Journal -Case Reports online.
Slide sets: A fully edited slide set detailing this case and suitable for local presentation is available online as Supplementary data.
